Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
TipRanks on MSN
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...
Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Researchers assessed disparities in COPD clinical trial participation based on gender, COPD severity, and geography and evaluated gender representation among researchers.
Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation ...
Quitting smoking and avoiding vaping may be crucial steps in managing COPD, as these habits expose your lungs to irritants that cause further damage. Quitting may slow the disease’s progression and ...
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
Samay founder and CEO Dr. Maria Artunduaga says things changed pretty quickly for her startup after winning the MedTech ...
Italy: A new 15-year analysis has revealed that patients with chronic obstructive pulmonary disease (COPD) who also have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback